Rockville, MD - Simvastatin (Zocor, Merck/Schering-Plough), used at the highest approved dose of 80 mg, is associated with an increased risk of myopathy, including rhabdomyolysis, according to the US ...
FDA review finds increased risk of muscle damage, kidney failure. June 9, 2011 — -- The U.S. Food and Drug Administration has recommended limiting high doses of a widely prescribed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback